Shenzhen YHLO Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was CNY 397.82 million compared to CNY 417.81 million a year ago. Revenue was CNY 397.82 million compared to CNY 417.81 million a year ago.
Net income was CNY 17.95 million compared to CNY 10.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.02 a year ago. Diluted earnings per share from continuing operations was CNY 0.03 compared to CNY 0.02 a year ago.
